Different Clinical Manifestations of Human Brucellosis in Pregnant Women : A Systematic Scoping Review of 521 Cases from 10 Countries
© 2020 Liu et al..
INTRODUCTION: This systematic scoping review aims to assess the frequency and severity of clinical manifestations of pregnant women with brucellosis.
METHODS: Three literature databases, PubMed, Web of Science and China National Knowledge Infrastructure (CNKI), and two search engines (Google and Yahoo) were adopted to identify the relevant articles that published until 31 December 2019. Two investigators independently screened the publications and extracted the data; the case reports and case series which described at least two symptoms or clinical manifestations of pregnant women with brucellosis were included.
RESULTS: A total of 27 articles describing the information of 521 pregnant women with brucellosis were included. Serum agglutination test was the most common laboratory test in the diagnosis of brucellosis. A total of 36 clinical manifestations were extracted from the included articles, and the most common clinical manifestations were fever (400, 76.8%), joint pain/swelling/arthralgia (389, 74.7%), sweats (382, 73.3%), fatigue/asthenia/weakness (262, 50.3%) and back pain (189, 36.3%). Among the 32 included individual cases that with available obstetric outcome information, 10 (31.3%) suffered preterm delivery, 12 (37.5%) had an abortion and 3 (9.8%) had intrauterine fetal death.
CONCLUSION: Brucellosis is popular and threatening for pregnant women. Regarding the localized body system complications, osteoarticular system was mostly involved, the obstetrics outcomes were severe among pregnant women with brucellosis. The detailed clinical and epidemiological characteristics in this scoping review may add a better and more complete understanding of the disease for both physicians and policy-makers, and provide evidence for timely diagnosis, adequate therapy and better prevention.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2020 |
---|---|
Erschienen: |
2020 |
Enthalten in: |
Zur Gesamtaufnahme - volume:13 |
---|---|
Enthalten in: |
Infection and drug resistance - 13(2020) vom: 27., Seite 1067-1079 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Liu, Zhe [VerfasserIn] |
---|
Links: |
---|
Themen: |
Human brucellosis |
---|
Anmerkungen: |
Date Revised 14.04.2022 published: Electronic-eCollection Citation Status PubMed-not-MEDLINE |
---|
doi: |
10.2147/IDR.S248779 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM309256852 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM309256852 | ||
003 | DE-627 | ||
005 | 20231225133518.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231225s2020 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.2147/IDR.S248779 |2 doi | |
028 | 5 | 2 | |a pubmed24n1030.xml |
035 | |a (DE-627)NLM309256852 | ||
035 | |a (NLM)32341659 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Liu, Zhe |e verfasserin |4 aut | |
245 | 1 | 0 | |a Different Clinical Manifestations of Human Brucellosis in Pregnant Women |b A Systematic Scoping Review of 521 Cases from 10 Countries |
264 | 1 | |c 2020 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Revised 14.04.2022 | ||
500 | |a published: Electronic-eCollection | ||
500 | |a Citation Status PubMed-not-MEDLINE | ||
520 | |a © 2020 Liu et al. | ||
520 | |a INTRODUCTION: This systematic scoping review aims to assess the frequency and severity of clinical manifestations of pregnant women with brucellosis | ||
520 | |a METHODS: Three literature databases, PubMed, Web of Science and China National Knowledge Infrastructure (CNKI), and two search engines (Google and Yahoo) were adopted to identify the relevant articles that published until 31 December 2019. Two investigators independently screened the publications and extracted the data; the case reports and case series which described at least two symptoms or clinical manifestations of pregnant women with brucellosis were included | ||
520 | |a RESULTS: A total of 27 articles describing the information of 521 pregnant women with brucellosis were included. Serum agglutination test was the most common laboratory test in the diagnosis of brucellosis. A total of 36 clinical manifestations were extracted from the included articles, and the most common clinical manifestations were fever (400, 76.8%), joint pain/swelling/arthralgia (389, 74.7%), sweats (382, 73.3%), fatigue/asthenia/weakness (262, 50.3%) and back pain (189, 36.3%). Among the 32 included individual cases that with available obstetric outcome information, 10 (31.3%) suffered preterm delivery, 12 (37.5%) had an abortion and 3 (9.8%) had intrauterine fetal death | ||
520 | |a CONCLUSION: Brucellosis is popular and threatening for pregnant women. Regarding the localized body system complications, osteoarticular system was mostly involved, the obstetrics outcomes were severe among pregnant women with brucellosis. The detailed clinical and epidemiological characteristics in this scoping review may add a better and more complete understanding of the disease for both physicians and policy-makers, and provide evidence for timely diagnosis, adequate therapy and better prevention | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Review | |
650 | 4 | |a human brucellosis | |
650 | 4 | |a pregnancy | |
650 | 4 | |a review | |
650 | 4 | |a signs and symptoms | |
700 | 1 | |a Wei, Dawei |e verfasserin |4 aut | |
700 | 1 | |a Li, Yanjun |e verfasserin |4 aut | |
700 | 1 | |a Zhou, Hao |e verfasserin |4 aut | |
700 | 1 | |a Huang, Desheng |e verfasserin |4 aut | |
700 | 1 | |a Guan, Peng |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Infection and drug resistance |d 2008 |g 13(2020) vom: 27., Seite 1067-1079 |w (DE-627)NLM209374322 |x 1178-6973 |7 nnns |
773 | 1 | 8 | |g volume:13 |g year:2020 |g day:27 |g pages:1067-1079 |
856 | 4 | 0 | |u http://dx.doi.org/10.2147/IDR.S248779 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 13 |j 2020 |b 27 |h 1067-1079 |